As of 2026-01-05, the Intrinsic Value of Beyond Medical Technologies Inc (DOCT.CN) is -1.19 CAD. This DOCT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.22 CAD, the upside of Beyond Medical Technologies Inc is -643.16%.
Based on its market price of 0.22 CAD and our intrinsic valuation, Beyond Medical Technologies Inc (DOCT.CN) is overvalued by 643.16%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.19 - -1.19 | -1.19 | -643.16% |
| P/E | 0.22 - 0.22 | 0.22 | 1.3% |
| DDM - Stable | (0.63) - (1.64) | (1.14) | -616.3% |
| DDM - Multi | (0.33) - (0.68) | (0.45) | -303.6% |
| Market Cap (mil) | 7.15 |
| Beta | 1.24 |
| Outstanding shares (mil) | 32.49 |
| Enterprise Value (mil) | 8.03 |
| Market risk premium | 5.10% |
| Cost of Equity | 10.16% |
| Cost of Debt | 5.00% |
| WACC | 10.10% |